Please assess the completion status of the following clinical trial:

Trial Title: Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood Tuberculosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Loss of more than 10% of maximum weight or failure to gain weight for 2 months.~* Having cough with wheeze for 4 weeks or more.~* History of household contact with a probable or confirmed tuberculosis case in the past 6 months.~* Pyrexia of unknown origin.~* Painless swelling in a group of cervical lymph nodes.~* Children who were diagnosed with TB in the past 5 years and have received anti-tuberculosis therapy for a period less than 4 weeks.~Exclusion Criteria:~-Children who have been treated with anti-tuberculosis therapy exceeding 4 weeks in the past one year will not be eligible for entry into the study

- Gender: ALL
- Minimum Age: 6 Weeks
- Maximum Age: 5 Years
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): Placebo
- Multivitamins (Type: EXPERIMENTAL): Multivitamin supplement containing the following vitamins: B1, B2, Niacin, B6, Folate, B12, C, and E

Based on this trial design, predict the completion outcome and termination type (if applicable).